GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 2 filers reported holding GENMAB A/S in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,343,037 | -6.2% | 94,784 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $3,563,861 | +27.3% | 93,761 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $2,799,683 | +109262.6% | 74,144 | +22.7% | 0.00% | 0.0% |
| Q4 2022 | $2,560 | -99.9% | 60,415 | +10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,763,000 | +2.2% | 54,862 | +3.3% | 0.00% | 0.0% |
| Q2 2022 | $1,725,000 | +161.4% | 53,098 | +191.1% | 0.00% | – |
| Q1 2022 | $660,000 | +8.0% | 18,243 | +18.1% | 0.00% | – |
| Q4 2021 | $611,000 | +135.0% | 15,451 | +160.0% | 0.00% | – |
| Q3 2021 | $260,000 | +20.4% | 5,942 | +12.5% | 0.00% | – |
| Q2 2021 | $216,000 | +0.5% | 5,282 | 0.0% | 0.00% | – |
| Q4 2020 | $215,000 | – | 5,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |